Neoplasma : Impact Factor & More
eISSN: 1338-4317pISSN: 0028-2685
Share this on:
Key Metrics
CiteScore 
4.2
Impact Factor
< 5
SNIP
0.62
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Neoplasma
Neoplasma Journal Specifications
| Overview | |
| Publisher | AEPRESS SRO |
| Language | English |
| Frequency | Bi-monthly |
| General Details |
View less
Planning to publish in Neoplasma ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Neoplasma
M2-TAM-derived XCL2 suppresses paclitaxel sensitivity in triple-negative breast cancer by transcriptionally activating NEK2.
- 15 Oct 2026
- Neoplasma
CtDNA retesting to guide anti-EGFR therapy in later-line metastatic colorectal cancer.
- 15 Oct 2026
- Neoplasma
Tissue carcinoembryonic antigen as a superior independent prognostic factor for colorectal cancer over serum CEA: a retrospective cohort study.
- 5 Oct 2026
- Neoplasma
LAMTOR5-AS1 predicts poor prognosis and regulates glioma progression via miR-4653-5p/TCF7 axis.
- 5 Oct 2026
- Neoplasma
Transcriptomic analysis of vitamin D3 (cholecalciferol)-mediated attenuation of cisplatin sensitivity in gastric cancer cells in vitro.
- 7 Sep 2026
- Neoplasma
Afatinib combined with oral metronomic vinorelbine as second-line treatment for advanced lung squamous cell carcinoma: a retrospective cohort study.
- 17 Aug 2026
- Neoplasma
M2-TAM-derived XCL2 suppresses paclitaxel sensitivity in triple-negative breast cancer by transcriptionally activating NEK2.
- 15 Oct 2026
- Neoplasma
CtDNA retesting to guide anti-EGFR therapy in later-line metastatic colorectal cancer.
- 15 Oct 2026
- Neoplasma
Tissue carcinoembryonic antigen as a superior independent prognostic factor for colorectal cancer over serum CEA: a retrospective cohort study.
- 5 Oct 2026
- Neoplasma
LAMTOR5-AS1 predicts poor prognosis and regulates glioma progression via miR-4653-5p/TCF7 axis.
- 5 Oct 2026
- Neoplasma
Transcriptomic analysis of vitamin D3 (cholecalciferol)-mediated attenuation of cisplatin sensitivity in gastric cancer cells in vitro.
- 7 Sep 2026
- Neoplasma
Afatinib combined with oral metronomic vinorelbine as second-line treatment for advanced lung squamous cell carcinoma: a retrospective cohort study.
- 17 Aug 2026
- Neoplasma
FAQs on Neoplasma
How long has Neoplasma been actively publishing? 
What is the publishing frequency of Neoplasma?
How many articles did Neoplasma publish last year?
What is the eISSN & pISSN for Neoplasma?
What is Citescore for Neoplasma?
What is SNIP score for Neoplasma?
Who is the publisher of Neoplasma?
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary
Your document is 100% secure & confidential We use 256-bit encryption for total security and
ISO/IEC 27001:2022 Certified
What all does the report include
01. Degree of Match
02. Common Topics
03. Additional
Recommendations
Recommendations